Authors : Ibrahimi Sara; Kdadri Sanae; Ibrahimi Mehdi; Saber Boutayeb; Ibrahim EL Ghissassi; Hind M’Rabti; Hassan Errihani

Volume/Issue : Volume 10 - 2025, Issue 9 - September

Google Scholar : https://tinyurl.com/y4dyfmmj

Scribd : https://tinyurl.com/nhdpp5as

DOI : https://doi.org/10.38124/ijisrt/25sep066

Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.

Note : Google Scholar may take 30 to 40 days to display the article.

Abstract : Synovial sarcoma is a rare mesenchymal tumor, usually found in the extremities. Its primary occurrence in the pleura is exceptional and presents a major diagnostic and therapeutic challenge. We report the case of a 53-year-old female patient presenting with progressive chest pain and dyspnea. Radiological imaging (chest X-ray and CT scan) revealed multiple large pleural masses with bilateral nodules. Pleural biopsy showed a spindle cell proliferation with mesenchymal features. Immunohistochemical analysis revealed strong expression of TLE1, while cytokeratins AE1/AE3, SATB2, S100, and desmin were negative. This immunophenotypic profile, combined with the morphological features, supported the diagnosis of pleural synovial sarcoma. In the absence of genetic confirmation of the t (X ;18) (p11 ; q11) translocation, the diagnosis relied on strong histopathological and immunohistochemical suspicion. Chemotherapy with anthracyclines was planned, but the patient unfortunately died before treatment initiation. Pleural synovial sarcoma is an extremely rare entity whose diagnosis depends on morphological, immunohistochemical, and ideally molecular findings. Its clinical presentation is often nonspecific, and its course can be rapidly unfavorable. TLE1 expression is a sensitive marker but not specific, highlighting the importance of a multidisciplinary diagnostic approach. This case underlines the necessity of considering synovial sarcoma in the differential diagnosis of unusual pleural masses, especially in younger patients. Rapid management is essential, although the prognosis remains poor in aggressive forms.

References :

1. Terry J et al. Prospective evaluation of TLE1 as à diagnostic immunohistochemical marker in synovial sarcoma. Am J Surg Pathol. 2007 ;31(2) :240–6.
2. Kosemehmetoglu K et al. TLE1 expression is not specific for synovial sarcoma : à whole section study of 163 soft tissue and bone neoplasms. Mod Pathol. 2009 ;22(7) :872–8.
3. Foo WC et al. Immunohistochemical staining for TLE1 distinguishes synovial sarcoma from histologic mimics. Am J Clin Pathol. 2011 ;135(6) :839–44.
4. Guillé F et al. Synovial sarcoma of the pleura : à clinical and pathologic study of three cases. J Thorac Cardiovasc Surg. 2002 ;124(4) :828–32.
5. P1.09-003. Malignant Mesothelioma Versus Synovial Sarcoma : An Analysis of 19 Cases with Molecular Diagnosis. J Thorac Oncol. 2017 ?
6. Modern Pathology group. Primary Pulmonary Poorly Differentiated Synovial Sarcoma : Transducer‑Like Enhancer of Split 1 Immunohistochemistry as A Valuable Diagnostic Aid. PMC. 2013.
7. Diagnostic Pathology group. Primary pleuropulmonary and mediastinal synovial sarcoma : clinicopathologic and molecular study of 26 cases. 2016.
8. MDPI editorial team. Synovial Sarcoma : A Clinical Review. Curr Treat Options Oncol. 2021 ;28(3) :177.
9. Bégueret H, Galateau-Sallé F, Guillou L, et al. Primary intrathoracic synovial sarcoma : à clinicopathologic study of 40 t (X ;18) -positive cases. Mod Pathol. 2005 ;18(5) :575–584. Doi :10.1038/modpathol.3800321
10. Dennison S, Weppler E, Giacoppe G. Primary pleuropulmonary synovial sarcoma : à case report and review of the literature. Lung Cancer. 2003 ;41(3) :353–359. Doi :10.1016/S0169-5002(03)00259-1
11. Rekhi B, Gorad BD, Chinoy RF. Monophasic synovial sarcomas : à study of their histomorphological, immunohistochemical, and ultrastructural spectrum. Indian J Pathol Microbiol. 2007 ;50(1) :12–16.
12. Foo WC, Cruise MW, Wick MR, Hornick JL. Immunohistochemical staining for TLE1 distinguishes synovial sarcoma from histologic mimics. Am J Clin Pathol. 2011 ;135(6) :839–844. Doi :10.1309/AJCPW5UJK3TJQGNN
13. Amodio J, Macías-García L, Rey-Búa B, et al. Monophasic synovial sarcoma of the pleura : diagnosis by histopathology and immunohistochemistry in a low-resource setting. Rev Esp Patol. 2019 ;52(3) :190–195. Doi : 10.1016/j.patol.2019.01.002
14. Issels RD, Lindner LH, Verweij J, et al. Neo-adjuvant chemotherapy alone or with regional hyperthermia for localized high-risk soft-tissue sarcoma : à randomized phase 3 multicentre study. Lancet Oncol. 2010 ;11(6) :561–570. Doi :10.1016/S1470-2045(10)70071-1
15. Palmerini E, Staals EL, Alberghini M, et al. Synovial sarcoma : retrospective analysis of 250 patients treated at a single institution. Cancer. 2009 ;115(13) :2988–2998. Doi :10.1002/cncr.24362.